Taro to Announce Second Quarter Results on November 7, 2017Taro Pharmaceutical Industries Ltd. (6:41PM)
Business Wire India
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the "Company") announced today that it plans to release its financial results for the quarter and six months ended September 30, 2017, on Tuesday, November 7, 2017.
The Company will conduct an earnings call at 8:00 am EST on Wednesday, November 8, 2017, where senior management will discuss the Company's performance and answer questions from participants.
The release will be accessible on Taro's website at www.taro.com.
Earnings Call (8:00 am EST on Wednesday, November 8, 2017)
To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.
Summary of events
Event Date and time Telephone number/ website Earnings release November 7, 2017 (AMC)
Earnings conference call
8:00 am EST
November 8, 2017
Participant Toll-Free Dial-In Number: +1 (844) 421-0601
Participant International Dial-In Number: +1 (716) 247-5800
Via audio webcast, details of which will be made available on www.taro.com
Replay of conference call November 8, 2017 to
November 30, 2017
+ 1 (855) 859-2056 or +1 (404) 537-3406
Via audio webcast playback, details of which will be made available on www.taro.com
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030006235/en/
HAWTHORNE, N.Y., United States